Publication | Closed Access
Radioimmunoassay: A Method for Human Chorionic Gonadotropin and Human Luteinizing Hormone1
760
Citations
0
References
1966
Year
FertilityHuman Chorionic GonadotropinGynecologyFemale Reproductive SystemFemale Reproductive FunctionReproductive BiologyOvarian CancerReproductive EndocrinologyHuman Luteinizing Hormone1Public HealthRadiation OncologyInfertilityEndocrine MechanismActive ProductEndocrinologyPharmacologyOvarian HormonePhysiologyPresumed OvulationReceptor BiologyMedicineReproductive HormoneGonadotropin Biology
A radioimmunoassay was developed using radioiodinated purified human chorionic gonadotropin and an antiserum that reacts specifically with both hCG and luteinizing hormone, yielding a sensitive and specific assay. The assay produced results comparable to the ovarian ascorbic acid depletion bioassay, could quantify normal luteinizing hormone levels in 0.1 ml of serum or urine, and detected LH peaks around ovulation. Published in Endocrinology 1966, vol.
Purified human chorionic gonadotropin has been radioiodinated to give an immunologically and biologically active product which possesses high specific activity. With this labeled hormone and an antiserum which is capable of reacting specifically with human luteinizing hormone and human chorionic gonadotropin, a sensitive and specific radioimmunoassay has been developed. Comparable results have been obtained when the content of luteinizing hormone in preparations differing widely in luteinizing and follicle stimulating activity have been estimated by the radioimmunoassay and the ovarian ascorbic acid depletion bio-assay. The assay is sufficiently sensitive to permit quantitation of normal amounts of luteinizing hormone in 0.1 ml of unconcentrated serum and urine. With the use of the assay, peaks in concentration of luteinizing hormone have been found in serum and urine of women near the time of presumed ovulation. (Endocrinology79: 10, 1966)